The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib

MLA

Julia Salleron, et al. “The Prognostic Value of Inflammation-Based Scores in Advanced Hepatocellular Carcinoma Patients Prior to Treatment with Sorafenib.” Oncotarget, vol. 8, Sept. 2017, pp. 95853–64. EBSCOhost, https://doi.org/10.18632/oncotarget.21401.

APA

Julia Salleron, M. Bensenane, Guillaume Conroy, Jean-Pierre Bronowicki, Anthony Lopez, Cédric Baumann, Hélène Barraud, Arthur Belle, Didier Peiffert, Abdelbasset Nani, & Ahmet Ayav. (2017). The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib. Oncotarget, 8, 95853–95864. https://doi.org/10.18632/oncotarget.21401

Chicago

Julia Salleron, M. Bensenane, Guillaume Conroy, Jean-Pierre Bronowicki, Anthony Lopez, Cédric Baumann, Hélène Barraud, et al. 2017. “The Prognostic Value of Inflammation-Based Scores in Advanced Hepatocellular Carcinoma Patients Prior to Treatment with Sorafenib.” Oncotarget 8 (September): 95853–64. doi:10.18632/oncotarget.21401.